4 completed, 2 terminated. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Terminated 2 |
| Phase 2 | 2 | Completed 2 |
Follow Michael Morse, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Niclosamide in Patients With Resectable Colon Cancer Niclosamide - Colon Cancer | Phase 1 | Terminated | Michael Morse, MD | 1 | 2017-11-07 | 2020-02-19 |
| Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer dHER2 + AS15 ASCI, Lapatinib - Metastatic Breast Cancer | Phase 1 / Phase 2 | Completed | Michael Morse, MD | 12 | 2009-07-01 | 2021-12-20 |
| A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Transplantation WT1 derived peptides - Acute Myelogenous Leukemia (AML), Chronic Myelogenous Leukemia (CML) | Phase 1 | Terminated | Michael Morse, MD | 8 | 2007-06-01 | 2013-12-10 |
| A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer tumor peptide vaccine - Epithelial Ovarian, Tubal or Peritoneal Cancer | Phase 1 | Completed | Michael Morse, MD | 8 | 2007-03-01 | 2012-11-19 |
| Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer falimarev, inalimarev, sargramostim - Colorectal Cancer, Metastatic Cancer | Phase 2 | Completed | Michael Morse, MD | 74 | 2005-02-01 | 2015-10-14 |
| Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer TRICOM-CEA(6D) - Breast Cancer, Colorectal Cancer | Phase 1 | Completed | Michael Morse, MD | 14 | 2002-01-01 | 2014-09-08 |
Colonic Neoplasms (3) · Breast Neoplasms (2) · Colorectal Neoplasms (2) · Ovarian Neoplasms (2) · Rectal Neoplasms (2) · Breast Neoplasms, Male (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Medullary (1) · Carcinoma, Ovarian Epithelial (1) · Gallbladder Neoplasms (1) · Head and Neck Neoplasms (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Liver Neoplasms (1) · Myelodysplastic Syndromes (1)
Lapatinib (1) · Niclosamide (1) · sargramostim (1)
United States (6)
Amy Hobeika, PhD (1) · Angeles A Secord, MD (1) · Herbert K. Lyerly, MD (1) · Michael A Morse, MD (1) · Michael A. Morse, MD (1) · Nelson Chao, MD (1) · Ramila Philip, PhD (1)
PMID 21300761, PMID 22325452, PMID 23657083
R21CA094523 (1)